MARIA NOLASCO: Open Payments
NPI 1316313190 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 6 payments from 5 companies in 2025. Trend: 2023 $564 · 2024 $228 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| SANOFI PASTEUR INC. | 1 | $120 |
| Novo Nordisk Inc | 2 | $65 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: BEYFORTUS, Ozempic, Rybelsus, BEXSERO, Kerendia, GVOKE HYPOPEN.
Industry payments across CA — which companies pay providers there.
